Current HIV prevention medication users often stigmatize other PrEP users as 'promiscuous'
August 19, 2024
August 19, 2024
EVANSTON, Illinois, Aug. 19 -- Northwestern University issued the following news release:
Journal: Sexes
CHICAGO - Public health messaging that drives stigma around Pre-exposure Prophylaxis (PrEP), a medication that can reduce HIV risk by up to 99%, appears to play a role in uptake of the medication. While the potential mismarketing of the drug is well-understood and has been studied extensively, few studies have examined factors associated with the perception of stigma . . .
Journal: Sexes
CHICAGO - Public health messaging that drives stigma around Pre-exposure Prophylaxis (PrEP), a medication that can reduce HIV risk by up to 99%, appears to play a role in uptake of the medication. While the potential mismarketing of the drug is well-understood and has been studied extensively, few studies have examined factors associated with the perception of stigma . . .